Pregled bibliografske jedinice broj: 1125652
Cancer drug resistance induced by EMT: novel therapeutic strategies
Cancer drug resistance induced by EMT: novel therapeutic strategies // Archives of toxicology, 95 (2021), 2279-2297 doi:10.1007/s00204-021-03063-7 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1125652 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Cancer drug resistance induced by EMT: novel therapeutic strategies
Autori
De Las Rivas, Javier ; Brozović, Anamaria ; Izraely, Sivan ; Casas-Pais, Alba ; Witz IP, Figueroa, Angelica.
Izvornik
Archives of toxicology (0340-5761) 95
(2021);
2279-2297
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Epithelial plasticity ; Cancer ; Therapy resistance ; Tumor microenvironment
(Epithelial plasticity ; Cancer ; Therapy resistance ; Tumor microenvironmen)
Sažetak
Over the last decade, important clinical benefits have been achieved in cancer patients by using drug-targeting strategies. Nevertheless, drug resistance is still a major problem in most cancer therapies. Epithelial-mesenchymal plasticity (EMP) and tumour microenvironment have been described as limiting factors for effective treatment in many cancer types. Moreover, epithelial-to-mesenchymal transition (EMT) has also been associated with therapy resistance in many different preclinical models, although limited evidence has been obtained from clinical studies and clinical samples. In this review, we particularly deepen into the mechanisms of which intermediate epithelial/mesenchymal (E/M) states and its interconnection to microenvironment influence therapy resistance. We also describe how the use of bioinformatics and pharmacogenomics will help to figure out the biological impact of the EMT on drug resistance and to develop novel pharmacological approaches in the future.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
HRZZ-IP-2016-06-1036 - Određivanje ključnih molekula epitelno-mezenhimalne tranzicije kao mogućih ciljeva za terapiju raka jajnika (DEvOuT) (Brozović, Anamaria, HRZZ - 2016-06) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Anamaria Brozović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE